Louisiana Administrative Code › Title 46 - PROFESSIONAL AND OCCUPATIONAL STANDARDS › Part LIII - Pharmacists › Chapter 15 - Hospital Pharmacy › Section LIII-1509 - Drug Distribution Control

Current through Register Vol. 50, No. 6, June 20, 2024
A.
				The hospital pharmacist-in-charge shall be responsible for the safe and
				efficient procurement, receipt, distribution, control, accountability, and
				patient administration and management of drugs. The staff of the hospital
				pharmacy shall cooperate with the pharmacist-in-charge in meeting drug control
				requirements in ordering, administering, and accounting for pharmaceuticals.
1. Procedure Manual. The pharmacist-in-charge
				shall maintain written procedures for the safe and efficient distribution of
				pharmaceutical products and delivery of pharmacy care. An updated copy shall be
				available for board inspection upon request.
2. Inventories. The pharmacist-in-charge
				shall:
a. perform an annual inventory on all
				controlled dangerous substances; and
b. maintain a perpetual inventory of Schedule
				I and II controlled dangerous substances.
3. Records. The pharmacist-in-charge shall be
				responsible for maintaining the following records:
a. a record of all drugs procured, the
				quantity received, and the name, address and wholesale distributor license
				number of the person from whom the drugs were procured;
b. all drug orders and records relating to
				the practice of pharmacy:
i. records of drugs
				dispensed shall include, but are not limited to:
(a). the name, strength, and quantity of
				drugs dispensed;
(b). the date of
				dispensing;
(c). the name of the
				hospital patient to whom, or for whose use, the drug was dispensed;
				and
(d). positive identification of
				all pharmacists involved in the dispensing;
ii. all other records relating to the
				practice of pharmacy other than dispensing shall include, but are not limited
				to:
(a). the name of the hospital patient to
				whom, or for whose benefit, the activity was performed;
(b). the nature of the pharmacy practice
				activity performed;
(c). the
				results of the activity, if applicable; and
(d). positive identification of all
				pharmacists involved in the activity; identifying the function performed by
				each pharmacist;
iii.
				Records of drugs dispensed to patients for use outside the hospital shall be
				maintained in compliance with
				Section
				1123 of this Part.
c. a record of all drugs
				compounded or prepackaged for use only within that hospital, which shall
				include at least the following:
i. name of
				drug, strength, quantity, and dosage form;
ii. manufacturer's or distributor's control
				number (except for patient-specific sterile compounded preparations);
iii. manufacturer's or distributor's name, if
				a generic drug is used;
iv.
				pharmacy control number;
v.
				manufacturer's or distributor's expiration date (except for patient-specific
				sterile compounded preparations);
vi. pharmacy's expiration date or beyond-use
				date;
vii. identification of the
				licensed person responsible for the compounding or prepackaging of the
				drug;
d. a record of the
				distribution of drugs to patient care areas and other areas of the hospital
				held for administration, which shall include at least the following:
i. the name, strength, dosage form, and
				amount of the drug distributed;
ii.
				the area receiving the drug;
iii.
				the date distributed;
iv.
				identification of the individual receiving the drug if it is a controlled
				dangerous substance;
v. the area of
				the hospital receiving the controlled dangerous substance shall make a record
				of all such drugs administered to patients. Such records shall include at least
				the following:
(a). name of the
				patient;
(b). name, dosage form,
				and strength when applicable of the drug;
(c). date and time the drug was
				administered;
(d). quantity
				administered;
(e). positive
				identification of the personnel administering the drug;
e. a log that shall be maintained
				of all changes made to a drug record in an electronic drug recordkeeping system
				after a drug transaction has been made. The log shall contain at least, but is
				not limited, to the following:
i. date and
				time of change;
ii. changes
				made;
iii. person making the
				change.